Torthaí cuardaigh - Henk‐Jan Guchelaar

Beachtaigh na torthaí
  1. 1
    Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients

    Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients de réir Romy Mosch, Henk‐Jan Guchelaar

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms

    The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms de réir Hendrikus Bernhard Bouwman, Henk‐Jan Guchelaar

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis

    Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis de réir Judith A.M. Wessels, T. Huizinga, Henk‐Jan Guchelaar

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands

    Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands de réir Paul CD Bank, Jesse J. Swen, Henk‐Jan Guchelaar

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

    Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines de réir Lisanne E. N. Manson, Jesse J. Swen, Henk‐Jan Guchelaar

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Clinical development of gene- and cell-based therapies: overview of the European landscape

    Clinical development of gene- and cell-based therapies: overview of the European landscape de réir Sofieke de Wilde, Henk‐Jan Guchelaar, Maarten L. Zandvliet, Pauline Meij

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time

    Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time de réir Emma C. Hulshof, Maarten J. Deenen, Henk‐Jan Guchelaar, Hans Gelderblom

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

    Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review de réir Sylvia D. Klomp, Martijn L. Manson, Henk‐Jan Guchelaar, Jesse J. Swen

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Technologies for Pharmacogenomics: A Review

    Technologies for Pharmacogenomics: A Review de réir Maaike van der Lee, Marjolein Kriek, Henk‐Jan Guchelaar, Jesse J. Swen

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

    Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice de réir Alireza Tafazoli, Henk‐Jan Guchelaar, Wojciech Miltyk, Adam Krętowski, Jesse J. Swen

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?—A Scoping Review

    3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?—A Scoping Review de réir Iris Lafeber, Elisabeth J. Ruijgrok, Henk‐Jan Guchelaar, Kirsten J. M. Schimmel

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Concordance of Predictive Markers for EGFR Inhibitors in Primary Tumors and Metastases in Colorectal Cancer: A Review

    Concordance of Predictive Markers for EGFR Inhibitors in Primary Tumors and Metastases in Colorectal Cancer: A Review de réir Jara M. Baas, L. L. Krens, Henk‐Jan Guchelaar, Hans Morreau, Hans Gelderblom

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Lapatinib for Advanced or Metastatic Breast Cancer

    Lapatinib for Advanced or Metastatic Breast Cancer de réir Frans L. Opdam, Henk‐Jan Guchelaar, Jos H. Beijnen, Jan H.M. Schellens

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)

    Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation pr... de réir Katja S. Just, Michael Steffens, Jesse J. Swen, George P. Patrinos, Henk‐Jan Guchelaar, Julia Stingl

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    The Risk of Cancer in Users of Statins

    The Risk of Cancer in Users of Statins de réir Matthijs R. Graaf, Annette B. Beiderbeck, Toine C. G. Egberts, Dick J. Richel, Henk‐Jan Guchelaar

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?

    Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options? de réir Jonathan E. Knikman, Hans Gelderblom, Jos H. Beijnen, Annemieke Cats, Henk‐Jan Guchelaar, Linda M. Henricks

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Liver and kidney function in patients with Covid‐19 treated with remdesivir

    Liver and kidney function in patients with Covid‐19 treated with remdesivir de réir Sylvia A. van Laar, Mark de Boer, Kim B. Gombert‐Handoko, Henk‐Jan Guchelaar, J. Zwaveling

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study

    Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study de réir E.R. Koomen, Arjen Joosse, Ron M. C. Herings, M. K. Casparie, Henk‐Jan Guchelaar, Tamar Nijsten

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Low literacy and written drug information: information-seeking, leaflet evaluation and preferences, and roles for images

    Low literacy and written drug information: information-seeking, leaflet evaluation and preferences, and roles for images de réir Mara M. van Beusekom, Petronella Grootens‐Wiegers, Mark Bos, Henk‐Jan Guchelaar, Jos M. van den Broek

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    The extent and effects of patient involvement in pictogram design for written drug information: a short systematic review

    The extent and effects of patient involvement in pictogram design for written drug information: a short systematic review de réir Mara M. van Beusekom, Anne H. Kerkhoven, Mark Bos, Henk‐Jan Guchelaar, Jos M. van den Broek

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: